Immunitybio Stock Options Expiring on 17th of January

IBRX Stock  USD 2.87  0.03  1.03%   

Immunitybio Market Cap Over Time

   Market Cap   
       Timeline  

Immunitybio Total Stockholder Equity

Total Stockholder Equity

(463.72 Million)

Immunitybio reported Total Stockholder Equity of (488.13 Million) in 2024

Immunitybio Corporate Management

Jason JDGeneral SecretaryProfile
Sandeep MDChief OfficerProfile
Helen LuuChief OfficerProfile
Leonard MDChief OfficerProfile
Jason LiljestromGeneral SecretaryProfile
Bruce MDSenior AffairsProfile

Additional Tools for Immunitybio Stock Analysis

When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.